Drägerwerk AG & Co. KGaA (ETR:DRW8)
51.60
+0.40 (0.78%)
May 8, 2025, 5:35 PM CET
Drägerwerk AG & Co. KGaA Revenue
Drägerwerk AG & Co. KGaA had revenue of 730.26M EUR in the quarter ending March 31, 2025, a decrease of -0.76%. This brings the company's revenue in the last twelve months to 3.37B, up 0.51% year-over-year. In the year 2024, Drägerwerk AG & Co. KGaA had annual revenue of 3.37B, down -0.08%.
Revenue (ttm)
3.37B
Revenue Growth
+0.51%
P/S Ratio
0.32
Revenue / Employee
210.14K
Employees
16,585
Market Cap
1.06B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.37B | -2.62M | -0.08% |
Dec 31, 2023 | 3.37B | 328.28M | 10.78% |
Dec 31, 2022 | 3.05B | -283.19M | -8.51% |
Dec 31, 2021 | 3.33B | -77.86M | -2.29% |
Dec 31, 2020 | 3.41B | 625.45M | 22.49% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Merck KGaA | 21.16B |
Siemens Healthineers AG | 22.67B |
Fresenius SE & Co. KGaA | 21.83B |
Bayer Aktiengesellschaft | 46.61B |
Sartorius Aktiengesellschaft | 3.44B |
Fresenius Medical Care AG | 19.49B |
Carl Zeiss Meditec AG | 2.08B |
Fielmann Group AG | 2.26B |
Drägerwerk AG & Co. KGaA News
- 6 days ago - Drägerwerk AG & Co KGaA (DGWPF) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Drägerwerk Sees Strong Q1 2025 Demand Surge - Wallstreet:Online
- 8 days ago - EQS-News: Drägerwerk AG & Co. KGaA: Dräger with strong demand in the first quarter of 2025 - Wallstreet:Online
- 24 days ago - Drägerwerk's Q1 2025 EBIT Dips, But Strong Orders Keep Forecast Bright - Wallstreet:Online
- 24 days ago - EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2025: EBIT below prior year – forecast confirmed due to good order development - Wallstreet:Online
- 5 weeks ago - EQS-AGM: Drägerwerk AG & Co. KGaA: Announcement of the Convening of the General Meeting in Lübeck on 09.05.2025 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution - Wallstreet:Online
- 5 weeks ago - Drägerwerk AG & Co. KGaA GAAP EPS of €6.61, revenue of €3.37B - Seeking Alpha
- 5 weeks ago - Drägerwerk AG & Co KGaA (DGWPF) Full Year 2024 Earnings Call Transcript - Seeking Alpha